(Reuters) – The UK health regulator said on Wednesday the available evidence does not establish a causal relationship between the popular class of weightloss drugs, including Novo Nordisk’s Wegovy, and suicidal thoughts.
(This story has been corrected to remove reference to Eli Lilly’s Zepbound in paragraph 1)
(Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)
Comments